Metabolomics signature improves the prediction of cardiovascular events in elderly subjects

Atherosclerosis

Volumn 232, Issue 2, 2014, Pages 260-264

  Rizza, S ^a   Copetti, M ^b   Rossi, C ^c   Cianfarani, M A ^a   Zucchelli, M ^c   Luzi, A ^a   Pecchioli, C ^a   Porzio, O ^a   Di Cola, G ^a   Urbani, A ^a,c   Pellegrini, F ^b   Federici, M ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Aging; MACE; Metabolomic; Mitochondrial dysfunction

Indexed keywords

ACYLCARNITINE; AMINO ACID; BLOOD CLOTTING FACTOR 7; CARNITINE; DECADIENOYLCARNITINE C 10 2; FATTY ACID DERIVATIVE; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MYRISTOYLCARNITINE C 14; PALMITOYLCARNITINE; UNCLASSIFIED DRUG;

AGE; AGED; ARTERY SURGERY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; GERIATRIC PATIENT; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; PREDICTION; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY;

AGING; MACE; METABOLOMIC; MITOCHONDRIAL DYSFUNCTION;

AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CARNITINE; CELL AGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOMICS; MYOCARDIAL INFARCTION; PRINCIPAL COMPONENT ANALYSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; STROKE;

EID: 84892835565     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.10.029     Document Type: Article

References (30)

1. Houtkooper R.H., Williams R.W., Auwerx J. Metabolic network of longevity. Cell 2010, 142:9-14.
2. Sahin E., Colla S., Liesa M., et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011, 470:359-365.
3. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subc. Circulation 2008, 117:e25-e146.
4. Shah S.H., Sun J.L., Stevens R.D., et al. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease. Am Heart J 2012, 163:844-850.
5. Psychogios N., Hau D.D., Peng J., et al. The human serum metabolome. PLoS One 2011, 6:e16957.
6. Rizza S., Gigli F., Galli A., et al. Adiponectin isoforms in elderly patients with or without coronary artery disease. JAm Geriatr Soc 2010, 58:702-706.
7. D'Agostino R.B., Russell M.W., Huse D.M., et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J 2000, 139:272-281.
8. Dorner T.E., Rieder A. Obesity paradox in elderly patients with cardiovascular diseases. Int J Cardiol 2012, 155:56-65.
9. Sirolli V., Rossi C., Di Castelnuovo A., et al. Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint. Blood Transfus 2012, 10(Suppl.2):s78-88.
10. Bonomini M., Di Liberato L., Del Rosso G., et al. Effect of an l-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with capd: a 4-month, prospective, multicenter randomized trial. Am J Kidney Dis 2013 May 28, pii: S0272-6386(13)00783-X. 10.1053/j.ajkd.2013.04.007.
11. Cureton E.E., Mulaik S.A. The weighted varimax rotation and the promax rotation. Psychometrika 1975, 40:183-195.
12. Ishwaran H., Kogalur U.B., Blackstone E.H., Lauer M.S. Random survival forests. Ann Appl Stat 2008, 2:841-860.
13. Pencina M.J., D'Agostino R.B. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004, 23:2109-2123.
14. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172.
15. Pencina M.J., D'Agostino R.B., Steyerberg E.W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011, 30:11-21.
16. Wang J.W., Larson M.G., Vasan R.S., et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011, 4:448-453.
17. Lum H., Sloane R., Huffman K.M., et al. Plasma acylcarnitines are associated with physical performance in elderly men. JGerontol A Biol Sci Med Sc 2011, 66:548-553.
18. Dai D., Rabinovitch P.S., Ungvari Z. Mitochondria and cardiovascular aging. Circ Res 2012, 110:1109-1124.
19. Ward M.S., Fortheringham A.K., Cooper M.E., Forbes J.M. Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease. Curr Opin Pharmacol 2013 Aug, 13(4):654-661.
20. Pujos-Guillot E., Pickering G., Lyan B., et al. Therapeutic paracetamol treatment in older persons induces dietary and metabolic modifications related to sulfur amino acids. Age (Dordr) 2012, 34(1):181-193.
21. Vitale C., Wajngaten M., Sposato B., et al. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease. Eur Heart J 2004, 25:1814-1821.
22. Newgard C.B., An J., Bain J.R., et al. Abranched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009, 9311-9326.
23. Shah S.H., Bain J.R., Muehlbauer M.J., et al. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet 2010, 3:207-214.
24. Houtkooper R.H., Argmann C., Houten S.M., et al. The metabolic footprint of aging in mice. Sci Rep 2011, 1:134.
25. Sampey B.P., Freemerman A.J., Zhang J., et al. Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS One 2012, 7:e38812.
26. Bayeva M., Gheorghiade M., Ardehali H. Mitochondria as a therapeutic target in heart failure. JAm Coll Cardiol 2013 Feb 12, 61(6):599-610.
27. Smith D.L., Nagy T.R., Allison D.B. Calorie restriction: what recent results suggest for the future of ageing research. Eur J Clin Invest 2010, 40:440-450.
28. Omodei D., Fontana L. Calorie restriction and prevention of age-associated chronic disease. FEBS Lett 2011, 585:1537-1542.
29. Di Napoli P., Taccardi A.A., Barsotti A. Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischemic dilated cardiomyopathy. Heart 2005, 91:161-165.
30. Kacar K., Rocca M.A., Copetti M., et al. Overcoming the clinical-MRI paradox of multiple sclerosis: MRI data assessed with a random forest approach. Am J Neuroradiol 2011 Dec, 32:2098-2102.